Professional Supply 99% Raw Steroid Anabolic Hormone Powders Semi-finished injection oils ,Oral oils,SARMS and Peptides.
Payment & Shipping Terms:
pharmaceutical grade powder
Fat Burnning Chemical Oral Sarm Powder / Sarms Bodybuilding SR9009 CAS 1379686-30-2
Whatsapp +86 13026161792
Product name: SR9009
CAS No 1379686-30-2
Molucelar weight 437.94026
SR9009, which is currently under development at The Scripps Research Institute (TSRI), increases the level of metabolic activity in skeletal muscles of mice. Treated mice become lean, develop larger muscles and can run much longer distances simply by taking SR9009, which mimics the effects of aerobic exercise. If similar effects can be obtained in people, the reversal of obesity, metabolic syndrome, and perhaps Type-II diabetes might be the very welcome result.
The drug was developed by Professor Thomas Burris, who found that it was able to reduce obesity in populations of mice. It binds to and activates a protein called Rev-ErbAα, which influences fat and sugar burning in the liver, production of fat cells, and the body's inflammatory response.
SR9009 is a research drug that was developed by Professor Thomas Burris of the Scripps Research Institute as an agonist ofRev-ErbA (i.e., increases the constitutive repression of genes regulated by Rev-ErbA)with a half-maximum inhibitory concentration (IC50) = 670 nM for Rev-ErbAα and IC50 = 800 nM for Rev-ErbAβ. Activation of Rev-erb-α by in mice SR9009 increases exercise capacity in mice by increasing mitochondria in skeletal muscle.
SR9009: The New Drug That Could Boost Exercise Tolerance
A new drug known as SR9009, which is presently under development at TSRI (The Scripps Research Institute) has been shown to considerably boost exercise endurance in animal models. Scientists think these discoveries may lead to improved cures for individuals suffering from illnesses that severely limit exercise endurance such as obesity, COPD (chronic obstructive pulmonary disease), congestive heart failure and also in the deterioration of muscle capacity linked with aging.
SR9009: A Drug That Might Cause A Major Breakthrough in Fitness
The drug was developed by Professor Thomas Burris who found that it was capable of reducing obesity in animal models, particularly mice. SR9009 which is an easy to dose oral compound can increase the level of metabolic activity in skeletal muscle of mice. The treated mice became lean, developed larger muscles and had a 50% increase in running abilities which imitates the effects of aerobic exercise.
The SR9009 binds to Rev-erbα (one of the body’s natural molecules) which influences lipid and glucose metabolism in the liver, the creation of fat-storing cells and the reaction of macrophages (cells that eliminate dying or dead cells) during inflammation.
How it works?
SR9009 treatment was shown to increase endurance and reverse mitochondrial damage in studies.
SR9009 has great promise in increased exercise capacity and endurance. This compound acts as an agonist of Rev-erbα. SR9009 binds to one of the body's natural molecules called Rev-erbα, which influences lipid and glucose metabolism in the liver, the production of fat-storing cells and the response of macrophages (cells that remove dying or dead cells) during inflammation.
Current studies show activation of Rev-erbα with SR9009 led to increased metabolic activity in skeletal muscle in culture,had a 50 percent increase in running capacity, measured by both time and distance.
SR9009 is an easy to dose oral compound that boosts metabolic activity in current studies.
SR9009 latches onto Rev-erbα -- which plays a role in regulating the body's circadian rhythm and metabolism -- resulting in a pronounced metabolic boost in test subjects.
Dosages and Suggestion
Dosages of 20-100mg a day have been reported by users without any negative side effects. From the information we have received, results from SR9009 treatment appear to be dose dependent up to a maximum dosage of 100mg per day. After this dosage, results tend to taper off.
We have the following SARMs manufactured:
|Product name||CAS No.||Specification|
Where can buy the Sarms.Sarms Raws Source.
|Enobosarm (Ostarine, MK-2866, GTx-024)|
|Andarine (S-4)||401900-40-1||partial agonist, intended mainly for treatment of benign prostatic hypertrophy|
|MK-677, Ibutamoren,||159752-10-0||a growth hormone secretagogue, treatment of obesity, a promising therapy for the treatment of frailty in the elderly|
|LGD-4033||1165910-22-4||pharmacological profile similar to that of enobosarm,|
|GW-501516||317318-70-0||It had been investigated as a potential treatment for obesity,diabetes,dyslipidemia and cardiovascular disease|
|AICAR||2627-69-2||AICAR acts by entering nucleoside pools, significantly increasing levels of adenosine during periods of ATP breakdown|
|Flibanserin||167933-07-5||developmental code name BIMT-17; that is being studied as a non-hormonal treatment for pre-menopausal women with HSDD.|
|Carphedon||77472-70-9||Phenylpiracetam (Phenotropil, Carphedon)|
|Coluracetam||135463-81-9||code name BCI-540; formerly MKC-231|
|Pirfenidone||53179-13-8||Pirespa, INN, BAN|